These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8607 related articles for article (PubMed ID: 18088454)

  • 21. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
    Jia XH; Zhu LP; Li JC; Wang CC
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C; Chillón MC; García-Sanz R; Balanzategui A; Sarasquete ME; Alcoceba M; Ramos F; Bernal T; Queizán JA; Peñarrubia MJ; Giraldo P; San Miguel JF; Gonzalez M
    Haematologica; 2008 Dec; 93(12):1797-805. PubMed ID: 18815192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA; Yahya RS; Elghannam DM; El-Khadragy AE; Abd El Messih HM
    Clin Lab; 2014; 60(1):55-61. PubMed ID: 24600975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRAME gene expression in childhood acute lymphoblastic leukemia.
    Steinbach D; Viehmann S; Zintl F; Gruhn B
    Cancer Genet Cytogenet; 2002 Oct; 138(1):89-91. PubMed ID: 12419593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mRNA expression of leukemia-associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies.
    Greiner J; Ringhoffer M; Taniguchi M; Li L; Schmitt A; Shiku H; Döhner H; Schmitt M
    Int J Cancer; 2004 Feb; 108(5):704-11. PubMed ID: 14696097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor associated antigen PRAME is a marker of favorable prognosis in childhood acute myeloid leukemia patients and modifies the expression of S100A4, Hsp 27, p21, IL-8 and IGFBP-2 in vitro and in vivo.
    Tajeddine N; Louis M; Vermylen C; Gala JL; Tombal B; Gailly P
    Leuk Lymphoma; 2008 Jun; 49(6):1123-31. PubMed ID: 18452107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the
    Zhang F; Lu AD; Zuo YX; Ding MM; Jia YP; Zhang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):543-549. PubMed ID: 35644195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression of CD66c (CEACM6) in adult acute leukemia and its significance].
    Chen BG; Yan WH; Meng ZF; Guo ZM; Zhu M; Li BL
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jun; 27(6):370-3. PubMed ID: 17147224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
    Guerrasio A; Pilatrino C; De Micheli D; Cilloni D; Serra A; Gottardi E; Parziale A; Marmont F; Diverio D; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Jun; 16(6):1176-81. PubMed ID: 12040450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implications of PRAME gene expression in childhood acute myeloid leukemia.
    Steinbach D; Hermann J; Viehmann S; Zintl F; Gruhn B
    Cancer Genet Cytogenet; 2002 Mar; 133(2):118-23. PubMed ID: 11943337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent aberration of FHIT gene expression in acute leukemias.
    Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
    Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The expression and clinical significance of early differentiation antigens in acute leukemia].
    Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
    Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferentially Expressed Antigen of Melanoma (PRAME) and Wilms' Tumor 1 (WT 1) Genes Expression in Childhood Acute Lymphoblastic Leukemia, Prognostic Role and Correlation with Survival.
    Khateeb EE; Morgan D
    Open Access Maced J Med Sci; 2015 Mar; 3(1):57-62. PubMed ID: 27275197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients.
    Cilloni D; Gottardi E; De Micheli D; Serra A; Volpe G; Messa F; Rege-Cambrin G; Guerrasio A; Divona M; Lo Coco F; Saglio G
    Leukemia; 2002 Oct; 16(10):2115-21. PubMed ID: 12357365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of hTERT gene expression in acute leukemia children].
    Li X; Wang X; Li X; Liu B; Zhang Y; Liao Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):486-8. PubMed ID: 12910697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of Philadelphia-chromosome-positive acute leukemia by clinical, immunocytochemical, and gene analysis.
    Tien HF; Wang CH; Chuang SM; Lee FY; Liu MC; Chen YC; Shen MC; Lin DT; Lin KH; Lin KS
    Leukemia; 1992 Sep; 6(9):907-14. PubMed ID: 1325582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of MUC1 gene and MDR1 gene in non-M3 subtype acute leukemia and their correlations to clinical treatment efficacy].
    Li GW; Wang DN; Lin DJ; Li XD; Lin GZ; He Y; Lin Q; Huang RW
    Ai Zheng; 2005 Aug; 24(8):1011-4. PubMed ID: 16086884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunophenotypic and clinical characteristic analysis of NPM1 mutated acute myeloid leukemia with a normal karyotype].
    Liu YR; Lai YY; Chang Y; Ruan GR; Qin YZ; Wang YZ; Zhu HH; Shi HX; Jiang B; Jiang H; Jiang Q; Hao L; Li JL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1385-9. PubMed ID: 24370016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expression of eIF4E in patients with leukemia and its clinical significance].
    Zhu LF; Chen XJ; Hu JD
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):1-6. PubMed ID: 23484680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 431.